🇺🇸 Opioid-Based Anesthesia-Analgesia Strategy in United States

Opioid-Based Anesthesia-Analgesia Strategy (Opioid-Based Anesthesia-Analgesia Strategy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Opioid-Based Anesthesia-Analgesia Strategy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Opioid-Based Anesthesia-Analgesia Strategy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Opioid-Based Anesthesia-Analgesia Strategy in United States?

University of Crete is the originator. The local marketing authorisation holder may differ — check the official source linked above.